|1.||Peura, David A: 9 articles (01/2015 - 06/2004)|
|2.||Huang, Bidan: 9 articles (01/2007 - 01/2002)|
|3.||Kinoshita, Yoshikazu: 8 articles (01/2015 - 02/2003)|
|4.||Atkinson, Stuart: 7 articles (05/2010 - 01/2008)|
|5.||Holbrook, Janet T: 6 articles (07/2015 - 01/2012)|
|6.||Lima, John J: 6 articles (07/2015 - 01/2012)|
|7.||Perez, M C: 6 articles (11/2013 - 04/2009)|
|8.||Haber, Marian M: 6 articles (05/2010 - 01/2002)|
|9.||Fass, R: 6 articles (06/2009 - 04/2000)|
|10.||Wong, W M: 6 articles (02/2006 - 06/2001)|
|1.||Gastroesophageal Reflux (GERD)
09/01/2005 - "Step-down lansoprazole therapy is considered very effective in terms of rapid effect, long-term effect and high quality GERD treatment."
02/15/2004 - "Lansoprazole dosages of 30 mg and 15 mg once daily provide a satisfactory decrease for oesophageal acid exposure and are equally effective for the treatment of gastro-oesophageal reflux disease in the Chinese population."
03/01/2008 - "The objective of this study was to assess the clinical efficacy of 2 dosing regimens of lansoprazole in infants with GERD using the revised infant gastroesophageal reflux questionnaire scores (I-GERQ-R). "
01/01/2010 - "Results of multicenter study "Efficacy of Lansoptol (lansoprazole, KRKA) and its influence on the Dynamics of GERD symptoms" (LIEDER) are presented. "
12/01/2005 - "Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients."
|2.||Duodenal Ulcer (Curling's Ulcer)
08/10/1998 - "In patients with an active or a recent history of duodenal ulcer, lansoprazole-based triple therapy for 10 or 14 days is highly effective in the eradication of H pylori. "
04/01/1998 - "In patients with active or a recent history of duodenal ulcer, a 14-day course of lansoprazole-based triple therapy without additional acid suppression therapy is highly effective in the eradication of H. "
10/01/1996 - "Lansoprazole was effective for prompt symptom relief in most patients and was able to heal more than 90% of gastric and duodenal ulcers with minimal side effects."
10/01/1995 - "Lansoprazole is an effective and safe treatment for duodenal ulcer and the 15 mg dose is as effective as 30 or 60 mg."
09/01/1995 - "It is shown that lansoprazole is effective and safe for treatment of duodenal ulcer."
09/01/2009 - "Both lansoprazole 15 and 30 mg were highly effective and well tolerated in reducing symptoms in subjects with frequent nighttime heartburn. "
08/20/2010 - "In addition, the proportion of 24-hour heartburn-free days (primary endpoint) was significantly greater in recipients of dexlansoprazole MR 30 mg once daily than in recipients of placebo following 4 weeks' treatment in a large, randomized, double-blind, multicentre phase III trial in patients with NERD. "
07/01/2001 - "Failure patients had significantly poorer health outcomes during their lansoprazole trial periods with significantly greater severity of heartburn and severity and frequency of acid regurgitation (P < 0.001). "
11/01/2013 - "NERD patients receiving dexlansoprazole 30 and 60 mg experienced significantly greater improvements in symptom severity for both heartburn and regurgitation compared with placebo. "
09/01/2009 - "Percentage of 24-h days without heartburn and percentage of subjects without heartburn on day 1 were significantly greater with lansoprazole 15 or 30 mg vs. placebo. "
09/01/1996 - "4-day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection."
09/01/1998 - "Lansoprazole quadruple therapy is effective in curing Helicobacter pylori infection."
05/01/1999 - "Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients."
11/01/2004 - "pylori infection, and to study the test performance after patients were treated with lanzoprazole, and after eradication therapy. "
08/01/2001 - "pylori infection, compared with a lansoprazole-based regimen, in a randomized multicentre study. "
01/01/1991 - "AG-1749 raised the percentage of time with high pH to 99% from the 68% obtained with an H2RA and cured 88% of this type of ulcer. "
07/01/2011 - "Lansoprazole is effective in healing non-steroidal anti-inflammatory drugs induced ulcers, and antioxidant properties have been thought to play a key role in healing ulcers. "
10/15/2003 - "Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial."
07/01/1999 - "Within 1 month of study initiation, 27% (four out of 15) of placebo-treated patients experienced ulcer recurrence as compared to 13% (two out of 15) and 6% (one out of 18) of lansoprazole 15 mg and 30 mg treated patients, respectively. "
01/01/1995 - "In study II, the ulcer contraction rate after 8 weeks of treatment with lansoprazole was 71.8%, significantly higher than that achieved with H2-receptor antagonists. "
|5.||Proton Pumps (Proton Pump)
|7.||Proton Pump Inhibitors